Carl Zeiss Meditec AG

1997. Expansion. DEWB AG, n/d

March 2000. IPO. DEWB AG, 89.78%, n/d

Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft (DEWB AG) has sold for cash its remaining interest, 2.39 million shares or 9% of all shares, in listed Carl Zeiss Meditec AG to unnamed institutional investors. DEWB AG partially exited its investment when the firm was merged in 2002 with Carl Zeiss Ophthalmic Systems AG to form Carl Zeiss Meditec AG. In September 2002 Carl Zeiss Meditec announced an increase in turnover of 6% to EUR 204.6m compared to EUR 193.3m in the previous year. EBIT reached EUR 8.4m compared to EUR 13.7m the previous year. Following US GAAP the business activities of former Asclepion have only been consolidated with effect from early July 2002.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• GPs
• DACH